SCHEMBL30101334

SCHEMBL30101334

c1cc2c(c(NC3CCOCC3)c1)CNC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TIPARP Q7Z3E1 3/20 0.43
MAPK1 P28482 3/20 0.39
CXCR2 P25025 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
JAK3 P52333 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3C2B O00750 1/20 0.34
MTOR P42345 1/20 0.34
CXCR4 P61073 2/20 0.33
BRD4 O60885 1/20 0.33
PIM1 P11309 2/20 0.33
QPCT Q16769 1/20 0.33
QPCTL Q9NXS2 1/20 0.33
CSF1R P07333 1/20 0.32
CD44 P16070 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24913829 1.00 TIPARP (0.43) TIPARPMAPK1CXCR2JAK2JAK1
SCHEMBL31062487 0.91 TIPARP (0.40) TIPARPBRD4
SCHEMBL24913959 0.91 TIPARP (0.40) TIPARPBRD4
SCHEMBL24914238 0.91 TIPARP (0.40) TIPARPBRD4
Hydrochloric Acid SCHEMBL30156740 0.90 TIPARP (0.39) TIPARPBRD4
Hydrochloric Acid SCHEMBL31013987 0.90 TIPARP (0.39) TIPARPBRD4
Hydrochloric Acid SCHEMBL31013858 0.90 TIPARP (0.39) TIPARPBRD4
Hydrochloric Acid SCHEMBL29008591 0.90 TIPARP (0.39) TIPARPBRD4
SCHEMBL24913935 0.84 TIPARP (0.34) TIPARPCXCR4CD44
SCHEMBL10269567 0.84 BRD4 (0.43) TIPARPJAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS RIBON THERAPEUTICS, INC. 2025-01-30 US disclosed
US-20240293392-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2024-09-05 US disclosed
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE 2023-06-22 US disclosed
US-11566020-B1 Pyridazinones as PARP7 inhibitors RIBON THERAPEUTICS, INC. (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240293392-A1 INHIBITOR COMPOUNDS MSH2, PMS2, MSH6 TIPARP 1544/4885MAPK1 525/4885CXCR2 3719/4885
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 TIPARP 152/4885MAPK1 1449/4885CXCR2 3806/4885
US-11566020-B1 Pyridazinones as PARP7 inhibitors PARP2, PARP1, PARP4 TIPARP 152/4885MAPK1 1449/4885CXCR2 3806/4885
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 TIPARP 152/4885MAPK1 1449/4885CXCR2 3806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.